SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-17
👔
Inhibrx Biosciences, Inc.
@INBX_InsiderForm 4 Filing: Kayyem Jon Faiz Buys $500K of $INBX
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Inhibrx Biosciences, Inc.
Ticker: $INBX
Transaction Value
$500K
Price/Share: $100.00
transaction date
2026-09-16
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kayyem Jon Faiz, holds the title of Director at Inhibrx Biosciences, Inc..
On 2026-09-16, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $100.00 per share, resulting in a total market-relevant value of $500K.
Executive Summary Summary
Kayyem Jon Faiz (Director) bought $500K of $INBX
Post-Transaction Position: 429,360 shares
SEC Accession No: 0001366268-26-000006 (CIK: 1366268)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.